Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer

Clinical trial NCT01348126 · TERMINATED

Trial details

NCT number: NCT01348126
Sponsor: Synta Pharmaceuticals Corp.
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Stage IIIB Non-small Cell Lung Cancer Stage IV Non-small Cell Lung Cancer Metastatic

Start date: 2011-05-01
Primary completion: 2014-04-01
Enrollment: 385

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.